英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Histine-Rich Basic Peptide (HRBP)(Aplysia californica) |
GLP-VAL-ALA-GLN-MET-HIS-VAL-TRP-ARG-ALA-VAL-ASN-HIS-ASP-ARG-ASN-HIS-GLY-THR-GLY-SER-GLY-ARG-HIS-GLY-ARG-PHE-LEU-ILE-ARG-ASN-ARG-TYR-ARG-TYR-GLY-GLY-GLY-HIS-LEU-SER-ASP-ALA |
|
詳細(xì)
|
Histone H1-derived peptide??;GGGPATPKKAKKL |
GLY-GLY-GLY-PRO-ALA-THR-PRO-LYS-LYS-ALA-LYS-LYS-LEU |
|
詳細(xì)
|
Histone H3 (1-25),amide,??;ARTKQTARKSTGGKAPRKQLATKAA-NH2 |
ALA-ARG-THR-LYS-GLN-THR-ALA-ARG-LYS-SER-THR-GLY-GLY-LYS-ALA-PRO-ARG-LYS-GLN-LEU-ALA-THR-LYS-ALA-ALA--NH2 |
|
詳細(xì)
|
Histone H3 (116–136), N15–39??;APRKQLATKAARKSAPATGGVKKPH |
ALA-PRO-ARG-LYS-GLN-LEU-ALA-THR-LYS-ALA-ALA-ARG-LYS-SER-ALA-PRO-ALA-THR-GLY-GLY-VAL-LYS-LYS-PRO-HIS |
|
詳細(xì)
|
HIV: gp120: 318-327 |
ARG-GLY-PRO-GLY-ARG-ALA-PHE-VAL-THR-ILE |
147841-68-7 |
詳細(xì)
|
HIV Peptide gp120 (254-274) |
CYS-THR-HIS-GLY-ILE-ARG-PRO-VAL-VAL-SER-THR-GLN-LEU-LEU-LEU-ASN-GLY-SER-LEU-ALA-GLU |
113944-46-0 |
詳細(xì)
|
HIV (gp120) Antigenic Peptide |
CYS-GLY-LYS-ILE-GLU-PRO-LEU-GLY-VAL-ALA-PRO-THR-LYS-ALA-LYS-ARG-ARG-VAL-VAL-GLN-ARG-GLU-LYS-ARG |
198636-94-1 |
詳細(xì)
|
HIV Substrate;KARVNleF(4-NO2)EANle-NH2 |
AC-ALA-ARG-VAL-LEU-ALA-GLU-ALA-NH2 |
128340-47-6 |
詳細(xì)
|
HIV QK10??;QVPLRMTYK |
GLN-VAL-PRO-LEU-ARG-MET-THR-TYR-LYS |
|
詳細(xì)
|
HIV-1 env Protein gp120 (278-292) (strains BH10, BH8, HXB2, HXB3, PV22) |
ARG-ILE-GLN-ARG-GLY-PRO-GLY-ARG-ALA-PHE-VAL-THR-ILE-GLY-LYS |
114991-28-5 |
詳細(xì)
|
HIV-1 env Protein gp41 (1-23) amide (isolates BRU/JRCSF) |
ALA-VAL-GLY-ILE-GLY-ALA-LEU-PHE-LEU-GLY-PHE-LEU-GLY-ALA-ALA-GLY-SER-THR-MET-GLY-ALA-ARG-SER--NH2 |
|
詳細(xì)
|
HIV-1 gag Protein p24 (137-154) |
GLY-LEU-ASN-LYS-ILE-VAL-ARG-MET-TYR-SER-PRO-THR-SER-ILE-LEU-ASP-ILE-ARG |
|
詳細(xì)
|
HIV-1 gag Protein p24 (194-210) |
ALA-ASN-PRO-ASP-CYS-LYS-THR-ILE-LEU-LYS-ALA-LEU-GLY-PRO-ALA-ALA-THR |
141281-67-6 |
詳細(xì)
|
HIV-1 gag Protein p24 (65-73) (isolates MAL/U455) |
ALA-MET-GLN-MET-LEU-LYS-ASP-THR-ILE |
334731-59-8 |
詳細(xì)
|
HIV-1 Tat (49-57) N-term Cys |
H-CYGRKKRRQRRR-NH2 |
|
詳細(xì)
|
HIV-1 tat Protein (49-57) |
HIV-1 tat Protein (49-57) |
123251-89-8 |
詳細(xì)
|
HIV-1, HIV-2 Protease Substrate;ATLNFPISPW |
ALA-THR-LEU-ASN-PHE-PRO-ILE-SER-PRO-TRP |
|
詳細(xì)
|
HIV (gp120) Fragment (308-331) |
ASN-ASN-THR-ARG-LYS-SER-ILE-ARG-ILE-GLN-ARG-GLY-PRO-GLY-ARG-ALA-PHE-VAL-THR-ILE-GLY-LYS-ILE-GLY |
115416-08-5 |
詳細(xì)
|
HIV (gp41) Antigenic Peptide 5 |
ARG-VAL-THR-ALA-ILE-GLU-LYS-TYR-LEU-GLN-ASP-GLN-ALA-ARG-LEU-ASN-SER-TRP-GLY-CYS-ALA-PHE-ARG-GLN-VAL-CYS-HIS-THR-THR-VAL-PRO-TRP-VAL-ASN-ASP-SER-NH2 (DISULFIDE BRIDGE: CYS20-CYS26) |
|
詳細(xì)
|
HIV (gp41) Fragment |
艾滋病病毒(抗原) |
129426-47-7 |
詳細(xì)
|
HLA-DQA1 (62 to 77) |
H-ALRNMAVAKHNLNIMI-OH |
|
詳細(xì)
|
HOE 140 |
艾替班特 |
130308-48-4 |
詳細(xì)
|
HPV-E6-N |
ASP-PRO-GLN-GLU-ARG-PRO-ARG-LYS-LEU-PRO-GLN-LEU-CYS-THR-GLU |
|
詳細(xì)
|
Human CMV Assemblin Protease Substrate (M-site) |
ARG-GLY-VAL-VAL-ASN-ALA-SER-SER-ARG-LEU-ALA-LYS |
|
詳細(xì)
|
CEF20, Cytomegalovirus, CMV pp65 (495-503);NLVPMVATV |
ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL |
153045-21-7 |
詳細(xì)
|
Human Papillomavirus E7 protein (49-57);RAHYNIVTF |
ARG-ALA-HIS-TYR-ASN-ILE-VAL-THR-PHE |
|
詳細(xì)
|
Hypercalcemia Malignancy Factor (1-34), amide, human |
ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU- ILE-HIS-THR-ALA-NH2 |
112955-31-4 |
詳細(xì)
|
Hydrin 1' |
CYS-TYR-ILE-GLN-ASN-CYS-PRO-ARG-GLY-GLY-LYS-ARG (DISULFIDE BRIDGE: CYS1-CYS6) |
148440-73-7 |
詳細(xì)
|
Hydrin 2 |
CYS-TYR-ILE-GLN-ASN-CYS-PRO-ARG-GLY-GLY (DISULFIDE BRIDGE: CYS1-CYS6)) |
122842-55-1 |
詳細(xì)
|
Hylambatin |
ASP-PRO-PRO-ASP-PRO-ASP-ARG-PHE-TYR-GLY-MET-MET-NH2 |
80890-46-6 |
詳細(xì)
|
Hypercalcemia Malignancy Factor (1-34), (PLP) human;AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA |
釋放肽pTH-Related Protein (1-34) |
112540-82-6 |
詳細(xì)
|
Hypercalcemia Malignancy Factor (1-40);AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTAEIRATS |
ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-GLU-ILE-ARG-ALA-THR-SER |
120298-73-9 |
詳細(xì)
|
Hypocretin (70-98) (human) |
HYPOCRETIN (70-98) (HUMAN) |
1129545-33-0 |
詳細(xì)
|
ICE Inhibitor III |
AC-TYR-VAL-ALA-ASP-FLUOROACYLOXYMETHYLKETONE: AC-YVAD-FLUOROACYLOXYMETHYLKETONE |
|
詳細(xì)
|
ig Endothelin-3: 1-41, amide, rat |
CYS-THR-CYS-PHE-THR-TYR-LYS-ASP-LYS-GLU-CYS-VAL-TYR-TYR-CYS-HIS-LEU-ASP-ILE-ILE-TRP-ILE-ASN-THR-PRO-GLU-GLN-THR-VAL-PRO-TYR-GLY-LEU-SER-ASN-HIS-ARG-GLY-SER-LEU-ARG-NH2: CTCFTYKDKECVYYCHLDIIWINTPEQTVPYGLSNHRGSLR-NH2DISULFIDE BRIDGES CYS1-CYS15, CYS3-CYS11 |
|
詳細(xì)
|
IL-8 (-5 to +5) |
ALA-VAL-LEU-PRO-ARG-SER-ALA-LYS-GLU-LEU |
|
詳細(xì)
|
IL-8 Inhibitor |
AC-ARG-ARG-TRP-TRP-CYS-ARG- NH2 |
138559-60-1 |
詳細(xì)
|
IL-8ra (9-29) |
AC-MET-TRP-ASP-PHE-ASP-ASP-LEU-ASN-PHE-THR-GLY-MET-PRO-PRO-ALA-ASP-GLU-ASP-TYR-SER-PRO-NH2 |
188689-66-9 |
詳細(xì)
|
Influenza A NP (366-374)??;ASNEMNDAM |
ALA-SER-ASN-GLU-MET-ASN-ASP-ALA-MET |
|
詳細(xì)
|
Insulin-Like Growth Factor I (30-41) |
GLY-TYR-GLY-SER-SER-SER-ARG-ARG-ALA-PRO-GLN-THR |
82177-09-1 |
詳細(xì)
|
IGF-I Analog |
CYS-TYR-ALA-ALA-PRO-LEU-LYS-PRO-ALA-LYS-SER-CYS |
147819-32-7 |
詳細(xì)
|
IL-1 b Converting Enzyme: ICE Substrate II |
4-4-DIMETHYLAMINOPHENYLAZOBENZOYL-TYR-VAL-ALA-ASP-ALA-PRO-VAL-5-[2-AMINOETHYLAMINO]-NAPHTHALENE-1-SULFONIC |
|
詳細(xì)
|
H-D-Ala-Gln-octadecyl ester · HCl |
H-D-ALA-GLN-OCTADECYL ESTER · HCL |
153508-74-8 |
詳細(xì)
|
H-D-Ala-Gln-OH |
D-丙氨酰-L-谷氨酰胺 |
205252-36-4 |
詳細(xì)
|
H-D-Ala-Gly-Gly-OH |
H-D-ALA-GLY-GLY-OH |
77286-90-9 |
詳細(xì)
|
H-D-Ala-Gly-OH |
D-丙氨酰甘氨酸 |
3997-90-8 |
詳細(xì)
|
H-D-Ala-Leu-Lys-AMC |
H-D-ALA-LEU-LYS-AMC |
104881-72-3 |
詳細(xì)
|
H-D-Ala-Phe-OH |
H-D-ALA-PHE-OH |
3061-95-8 |
詳細(xì)
|
H-D-Ala-Pro-OH |
H-D-ALA-PRO-OH |
61430-12-4 |
詳細(xì)
|
H-D-Arg-Gly-Asp-Trp-OH |
H-D-ARG-GLY-ASP-TRP-OH |
|
詳細(xì)
|
H-D-Arg-Phe-OH |
H-D-ARG-PHE-OH |
133410-92-1 |
詳細(xì)
|
H-D-Glu(Gly-OH)-OH |
Γ-D-谷氨?;拾彼?/td>
| 6729-55-1 |
詳細(xì)
|
H-Glu(Trp-OH)-OH |
免疫調(diào)節(jié)二肽Bestim |
66471-20-3 |
詳細(xì)
|
H-D-Glu-D-Glu-OH |
H-D-GLU-D-GLU-OH |
6729-94-8 |
詳細(xì)
|
H-D-Ile-Asp-OH |
H-D-ILE-ASP-OH |
120067-35-8 |
詳細(xì)
|
H-D-Ile-Phe-Lys-pNA |
H-D-ILE-PHE-LYS-PNA |
76626-41-0 |
詳細(xì)
|
H-DL-Ala-DL-Ala-OH |
DL-丙氨酰-DL-氨基丙酸 |
2867-20-1 |
詳細(xì)
|
H-DL-Ala-DL-Leu-Gly-OH |
H-DL-ALA-DL-LEU-GLY-OH |
82267-71-8 |
詳細(xì)
|
H-DL-Ala-DL-Leu-OH |
DL-丙氨酰基-DL-亮氨酸 |
1999-42-4 |
詳細(xì)
|
H-DL-Ala-DL-Met-OH |
DL-丙氨?;?DL-蛋氨酸 |
1999-43-5 |
詳細(xì)
|
H-DL-Ala-DL-Phe-OH |
DL-丙氨?;?DL-苯基丙氨酸 |
1999-45-7 |
詳細(xì)
|
H-DL-Ala-DL-Val-OH |
DL-丙氨酰基-DL-纈氨酸 |
1999-46-8 |
詳細(xì)
|
H-DL-Ala-Gly-Gly-OH |
DL-丙氨酰-甘氨酰-甘氨酸二水合物 |
927-21-9 |
詳細(xì)
|
H-DL-Ala-Gly-OH |
DL-丙氨酰甘氨酸 |
1188-01-8 |
詳細(xì)
|
H-D-Leu-D-Leu-OH |
H-D-LEU-D-LEU-OH |
38689-30-4 |
詳細(xì)
|
H-D-Leu-Gly-Gly-OH |
D-亮氨?;?甘氨?;?甘氨酸 |
18625-22-4 |
詳細(xì)
|
H-D-Leu-Gly-OH |
D-亮氨酰甘氨酸 |
997-05-7 |
詳細(xì)
|
H-D-Leu-Leu-OH |
H-D-LEU-LEU-OH |
38689-31-5 |
詳細(xì)
|
H-D-Leu-Thr-Arg-pNA |
H-D-Leu-Thr-Arg-pNA |
122630-72-2 |
詳細(xì)
|
H-D-Leu-Tyr-OH |
D-亮氨酰-L-酪氨酸水合物 |
3303-29-5 |
詳細(xì)
|
H-D-Phg-Leu-OH |
H-D-PHG-LEU-OH |
110207-44-8 |
詳細(xì)
|
H-D-Pro-Phe-Arg-pNA · 2 HCl |
H-D-PRO-PHE-ARG-PNA · 2 HCL |
62354-56-7 |
詳細(xì)
|
H-D-Trp-D-Met-p-chloro-D-Phe-Gla-NH2 |
H-D-TRP-D-MET-P-CHLORO-D-PHE-GLA-NH2 |
178396-45-7 |
詳細(xì)
|
Head Activator;Pyr-PPGGSKVILF |
GLP-PRO-PRO-GLY-GLY-SER-LYS-VAL-ILE-LEU-PHE |
|
詳細(xì)
|
Hemoglobin (Hb) (64-76);GKKVITAFNEGLK |
GLY-LYS-LYS-VAL-ILE-THR-ALA-PHE-ASN-GLU-GLY-LEU-LYS |
|
詳細(xì)
|
Hemokinin 1 (mouse, rat) |
ARG-SER-ARG-THR-ARG-GLN-PHE-TYR-GLY-LEU-MET-NH2 |
208041-90-1 |
詳細(xì)
|
Hepatitis A Virus (HAV) 3C Protease Substrate |
DABCYL-GLY-LEU-ARG-THR-GLN-SER-PHE-SER-EDANS |
145682-87-7 |
詳細(xì)
|
Hepatitis Virus C NS3 Protease Inhibitor 1 |
AC-ASP-GLU-MET-GLU-GLU-CYS |
|
詳細(xì)
|
Hepcidin-25 (human) |
ASP-THR-HIS-PHE-PRO-ILE-CYS-ILE-PHE-CYS-CYS-GLY-CYS-CYS-HIS-ARG-SER-LYS-CYS-GLY-MET-CYS-CYS-LYS-THR |
342790-21-0 |
詳細(xì)
|
Hirudin (54-65) (desulfated) |
水蛭素 |
113274-56-9 |
詳細(xì)
|
Histatin-3 (H3);DSHAKRHHGYKRKFHEKHHSHRGYRSNYLYDN |
ASP-SER-HIS-ALA-LYS-ARG-HIS-HIS-GLY-TYR-LYS-ARG-LYS-PHE-HIS-GLU-LYS-HIS-HIS-SER-HIS-ARG-GLY-TYR-ARG-SER-ASN-TYR-LEU-TYR-ASP-ASN |
|
詳細(xì)
|
Histatin-5;DSHAKRHHGYKRKFHEKHHSHRGY |
組蛋白5 |
104339-66-4 |
詳細(xì)
|
H-DL-Leu-DL-Ala-OH |
H-DL-LEU-DL-ALA-OH |
5060-46-8 |
詳細(xì)
|
H-DL-Leu-DL-Phe-OH |
DL-亮氨酰-DL-苯丙氨酸 |
56217-82-4 |
詳細(xì)
|
H-DL-Leu-DL-Tyr-OH |
H-DL-LEU-DL-TYR-OH |
19659-00-8 |
詳細(xì)
|
H-DL-Leu-Gly-DL-Phe-OH |
DL-亮氨酰-甘氨酰-DL-苯丙氨酸 |
4294-25-1 |
詳細(xì)
|
H-DL-Leu-Gly-Gly-OH |
DL-亮氨酰-甘氨酰-甘氨酸 |
4337-37-5 |
詳細(xì)
|
H-DL-Leu-Gly-OH |
DL-亮氨酰甘氨酸 |
615-82-7 |
詳細(xì)
|
H-DL-Val-Leu-Arg-pNA |
H-DL-VAL-LEU-ARG-PNA |
117961-22-5 |
詳細(xì)
|
H-D-Met-D-Met-OH |
H-D-MET-D-MET-OH |
89680-20-6 |
詳細(xì)
|
H-D-Met-Met-Met-OH |
H-D-MET-MET-MET-OH |
319927-24-7 |
詳細(xì)
|
H-D-Met-Met-OH |
H-D-MET-MET-OH |
89680-17-1 |
詳細(xì)
|
H-D-Phe-Ala-OH |
H-D-PHE-ALA-OH |
80924-58-9 |
詳細(xì)
|
H-D-Phe-D-Phe-OH |
H-D-PHE-D-PHE-OH |
58607-69-5 |
詳細(xì)
|
H-D-Phe-Homopro-Arg-pNA · 2 acetate |
H-D-PHE-HOMOPRO-ARG-PNA · 2 ACETATE |
386253-60-7 |
詳細(xì)
|
H-D-Phe-Pro-Arg-5-amido-isophthalic acid-dimethyl ester |
H-D-PHE-PRO-ARG-5-AMIDO-ISOPHTHALIC ACID-DIMETHYL ESTER |
|
詳細(xì)
|
H-D-Phe-Pro-Arg-chloromethylketone |
H-D-苯丙酰氨-脯酰氨-精氨酸-氯甲基酮三氟乙酸 |
71142-71-7 |
詳細(xì)
|
H-D-Phe-Pro-OH |
H-D-PHE-PRO-OH |
51926-52-4 |
詳細(xì)
|
H-D-Phe-Ser(Bzl)-Phe-OH |
H-D-PHE-SER(BZL)-PHE-OH |
|
詳細(xì)
|
H-D-Phe-Ser(Bzl)-Phe-Phe-Ala-Ala-4-Abz-OH |
H-D-PHE-SER(BZL)-PHE-PHE-ALA-ALA-4-ABZ-OH |
|
詳細(xì)
|